Results

Total Results: 230 records

Showing results for "liver".
Users also searched for: hepatitis c

121. Screening and Treatment for Hypercholesterolemia in Children and Adolescents: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
     January 01, 2007 - LDH and abnormalities in AST that persisted for six months,211 but 20 others showed normal liver … over 4.3 years of treatment and found to be normal.225 Two studies of niacin reported increased liver … No effects on muscle or liver enzyme levels. … No increase in liver enzymes. De Jongh, 2003206 Various statins 69, 10-18 y NR None observed. … No effect on CBC, liver function tests, vitamin A and E, calcium, phosphorus, blood urea nitrogen,

122. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholerolemia: Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dCH2CMqVyAzf4eyj-ch6H3
     August 09, 2016 - Supplement).21,22,25-28,35-48 Statins were generally well toler- ated, although reversible elevations of liver … Six of 11 studies assessing liver transaminase and creatine kinase concentrations found no abnormalities

123. PII: S0749-3797(01)00255-0 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
     January 01, 2001 - Elevations in liver enzyme levels, which some studies have noted, have not been found in recent large … upset for gemfibrozil or bile-acid binding resins; flush- ing for niacin) or rare major effects (e.g., liver

124. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
     April 09, 2001 - Elevations in liver enzyme levels, which some studies have noted, have not been found in recent large … upset for gemfibrozil or bile-acid binding resins; flushing for niacin) or rare major effects (e.g., liver

125. Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - proteinuria, preeclampsia is diagnosed as hypertension with any of the following: thrombocytopenia, impaired liver

126. Archived: Dementia in Older Adults: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/dementia-older-adults-screening-1996
     January 01, 1996 - doses, and two thirds of those on high doses, stopped therapy due to nausea, vomiting, or elevated liver

127. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
     April 01, 2016 - duration of use, history of GI ulcers or upper GI pain, bleeding disorders, renal failure, severe liver … duration of use, history of GI ulcers or upper GI pain, bleeding dis- orders, renal failure, severe liver

128. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
     November 01, 2021 - Dig Liver Dis. 2012;44(8):700-704. 57. Guittet L, Bouvier V, Guillaume E, et al. … Dig Liver Dis. 2012;44(8):694- 699. 58. Guittet L, Bouvier V, Mariotte N, et al. … Dig Liver Dis. 2013;45(8): 645-650. 146.

129. Low-Dose Aspiring for the Prevention of Morbidity and Mortality from Preeclampsia: A Systematic Evidence Review fro the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6W538pkN7ft6TsRMKfPWMJ
     May 27, 2014 - features” with any of the following: blood pressure above 160/110 mm Hg, thrombocytopenia, impaired liver … Preeclampsia with or without severe features can evolve rapidly into eclampsia or the hemolysis, elevated liver … neonatal death Harms 2 3 1 ARDS � acute respiratory distress syndrome; HELLP � hemolysis, elevated liver

130. Archived: Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-june-2017
     June 20, 2017 - Reporting trials generally showed no differences in liver or kidney function, and there were no reported … Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth … Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents

131. Archived: Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
     June 15, 2016 - Dig Liver Dis . 2012;44(8):700-704. 57. Guittet L, Bouvier V, Guillaume E, et al. … Dig Liver Dis . 2012;44(8):694-699. 58. Guittet L, Bouvier V, Mariotte N, et al. … Dig Liver Dis . 2013;45(8):645-650. 146.

132. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ymZSPeLcwZ9rxTC-7zdWbp
     July 11, 2022 - , preeclampsia is diagnosed as hypertension with any of the following: thrombocytopenia, im- paired liver

133. Evidence Summary: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
     July 18, 2023 - Limited longer-term evidence shows few withdrawals due to adverse events, slightly higher rates of liver … Clinical importance of transient elevations in these laboratory values is unknown Low for reversible liver

134. Preeclampsia Screening Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgA7neX9UurPQRh3pJaYXY
     April 25, 2017 - proteinuria, additional features contribute to diagnosis (ie, thrombocytopenia, renal insufficiency, impaired liver … that re- ported on maternal and infant mortality, morbidity from eclampsia, HELLP (hemolysis, elevated liver … diagnose preeclampsia in the absence of proteinuria, including cerebral or visual symptoms, impaired liver

135. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/abTWXPvJyAMcqN9KcEt-vt
     September 06, 2016 - In the IUAT study, all 3 participants who died of hepatitis had continued to take isoniazid after liver … Isoniazid chemoprophylaxis: association with detection and incidence of liver toxicity. … ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver

136. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
     August 23, 2022 - increased risk of withdrawal because of adverse events, serious adverse events, cancer, or elevated liver … additional CHD risk factor Excluded: use of lipid-lowering therapy, intolerant of statins, significant liver

137. Archived: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening-2014
     March 18, 2014 - which had very high discontinuation rates in trials, has an uncommon but serious adverse effect of liver

138. Archived: Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - with drug treatment (e.g., myopathy, rhabdomyolysis, myalgia, cognitive loss, diabetes, elevations in liver

139. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
     May 18, 2021 - Dig Liver Dis . 2012;44(8):700-704. doi:10.1016/j.dld.2012.03.015 63. … Dig Liver Dis . 2017;49(5):557-561. doi:10.1016/j.dld.2016.12.020 114. … Dig Liver Dis . 2013;45(8):645-650. doi:10.1016/j.dld.2013.02.020 191.

140. Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/rQBBkz9CrHh4vp7ZnEkF-t
     July 18, 2023 - Clinical importance of transient elevations in these laboratory values is unknown Low for reversible liver … Limited longer-term evidence shows few withdraw- als due to adverse events, slightly higher rates of liver